AdExchanger
Oracle Advertising’s Customers Are Up For Grabs; The Reddit Third Rail
In an AdExchanger daily news roundup, Dstillery is highlighted for its readiness to take on Oracle Advertising clients, amidst the shutdown.
Press
Latest
More Press
MarTech Series
A Better Patient Targeting Solution for Healthcare Brands
As all advertisers grapple with data restrictions already well-known in healthcare, innovation across the ad industry opens new opportunities for healthcare brands. Dstillery's SVP of Product, Taejin In, explains more in his guest article for…
Read more
Publications Office of the European Union
Study on the Impact of Recent Developments in Digital Advertising on Privacy, Publishers & Advertisers
The European Commission issued a report on all things privacy and digital advertising. Our SVP of Strategy & Partnerships, Evan Hills was included in their research discussing our ID-free® targeting approach as an alternative model…
Read more
IAB
IAB’s 2023 State of Data Report
We're a proud sponsor of IAB's 2023 State of Data Report, "Data Clean Rooms & the Democratization of Data in the Privacy-Centric Ecosystem." Download your copy today.
Read more
AdExchanger
How Dstillery And PurpleLab Are Targeting Pharma Ads Without Personal Identifiable Information
Dstillery launched a new version of Custom Patient Targeting integrated with PurpleLab, making the solution even more custom and precise. Read how the partnership is changing the healthcare targeting landscape.
Read more
Stravito
The State of Insights 2023 featuring Gilad Barash, Dstillery’s VP of Analytics
Gilad Barash talks insights, cookieless future, and how to enable meaningful engagement in Stravito's State of Insights 2023. Read the report.
Read more
Digiday
Dstillery Named a Winner for the Digiday Technology Awards, Best Data Lead and Best Data Team
We're very excited to have won 2 categories in the Digiday Technology Awards. Named 'Best Data Lead' and 'Best Data Team,' we are honored to be recognized for our highly talented Data Science Team and…
Read more
